About Daffohils Laboratories
Daffohils Laboratories is a Healthcare company. Pharmaceutical manufacturing and third-party services in India. The company has 64 employees. Its Indian entity Daffohils Laboratories Private Limited reported revenue of ₹22.11 Cr. Daffohils Laboratories offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Manufacturing, Drug Production and Export.
Company details
Daffohils Laboratories is recognized as a prominent third-party pharma manufacturer in India, with a focus on providing effective and safe pharmaceutical products. A diverse array of items, including tablets, capsules, syrups, and ointments, is offered by the company, all approved by regulatory bodies such as the State Drug Controller and DCGI. Certifications like WHO-GMP and ISO are maintained, ensuring consistent quality and compliance. The company is noted for its commitment to affordable healthcare solutions and has established partnerships across multiple countries, driven by values of honesty and innovation. Exports to regions like Mali and UAE are facilitated, emphasizing global reach in the pharmaceutical sector. Over 27 years of experience is reflected in its operations, supporting stakeholders through reliable manufacturing practices.
- Employees 64
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook Instagram
- Legal Name Daffohils Laboratories Pvt Ltd
- Date of Incorporation 14 May, 2004
- Jurisdiction Dehradun, Uttarakhand, India
- Indian entity revenue₹22.11 Cr
FY 2025 · -10% YoY
- Indian entity net profit₹29.7 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹1.20 Cr
FY 2025 · 5% margin
- Employee Count64
Associated legal entities of Daffohils Laboratories
Daffohils Laboratories operates through Daffohils Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Daffohils Laboratories Private Limited CIN U24232UR2004PTC028623 | Active | 14 May 2004 | Dehradun, Uttarakhand | ₹22.1 Cr | 64 | 2 | View details |
Products & Services of Daffohils Laboratories
Daffohils Laboratories offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured for healthcare purposes under certified standards
Capsules are produced for various medicinal applications with adherence to quality protocols
Board of directors of Daffohils Laboratories Private Limited (Daffohils Laboratories)
Daffohils Laboratories Private Limited is the primary company behind Daffohils Laboratories. The board of Daffohils Laboratories Private Limited currently have 2 directors; the longest-serving is Inderpal Singh Chawla, appointed in 2004. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Inderpal Singh Chawla DIN 00189169 | Managing Director | 14 May 2004 | 22 yrs 5 mo | Daffohils Laboratories Private Limited |
| Sunit Chawla DIN 08450887 | Director | 05 Mar 2021 | 5 yrs 7 mo | Daffohils Laboratories Private Limited |
Financials of Daffohils Laboratories
Figures of Daffohils Laboratories Private Limited, the primary company behind Daffohils Laboratories, for FY 2025. Revenue was ₹22.11 Cr (-10% year on year). Net profit was ₹29.7 Lakh (1% margin). EBITDA was ₹1.20 Cr (5% margin). Revenue has grown at a compounded annual rate of -4% over three years and 0% over five years.
- ₹22.11 CrRevenue · FY 2025 · -10% YoY
- ₹29.7 LakhNet profit · 1% margin
- ₹1.20 CrEBITDA · 5% margin
- ₹2.00 CrPaid-up capital
- 64Employees (provident fund records)
- -4%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Daffohils Laboratories Private Limited are on its company page.
Detailed financial statements for Daffohils Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Daffohils Laboratories
Daffohils Laboratories has 64 employees.
The primary company behind Daffohils Laboratories, Daffohils Laboratories Private Limited, reported revenue of ₹22.11 Cr for FY 2025, down 10% year on year.
Daffohils Laboratories is recognized as a prominent third-party pharma manufacturer in India, with a focus on providing effective and safe pharmaceutical products. A diverse array of items, including tablets, capsules, syrups, and ointments, is offered by the company, all approved by regulatory bodies such as the State Drug Controller and DCGI. Certifications like WHO-GMP and ISO are maintained, ensuring consistent quality and compliance. The company is noted for its commitment to affordable healthcare solutions and has established partnerships across multiple countries, driven by values of honesty and innovation. Exports to regions like Mali and UAE are facilitated, emphasizing global reach in the pharmaceutical sector. Over 27 years of experience is reflected in its operations, supporting stakeholders through reliable manufacturing practices.
Daffohils Laboratories offers Tablets and Capsules.
Daffohils Laboratories operates through Daffohils Laboratories Private Limited.
The legal entities of Daffohils Laboratories currently have 2 directors, including Inderpal Singh Chawla, Sunit Chawla.